Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this maintenance update does not affect the study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedEditorial updates to the Publications section clarify that items are auto-filled from PubMed and may not all pertain to the study; revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedThe government funding status notice on the page has been removed.SummaryDifference0.1%

- Check46 days agoChange DetectedTwo location entries in the Locations list were renamed from 'Santiago de Cali' to 'Cali' for postal codes 76001 and 760042 in Valle del Cauca, Colombia.SummaryDifference0.2%

- Check67 days agoChange DetectedLocation naming updated from Bourgogne to Bourgogne-Franche-Comté for Dijon, France (21000); the core location data remains the same.SummaryDifference0.0%

- Check75 days agoChange DetectedMajor updates include a government-operating-status notice and a version bump to v3.2.0. The page now informs users about potential service disruption due to funding and provides links for status updates.SummaryDifference1%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.